Jmcgh and Other Sites: Urine Sites
Only
Numbers are percent
susceptible
|
Gram Negative Organisms |
No.of isolates |
amk |
am/s |
cz |
fep |
caz |
cx |
esbl (+) |
etp |
gm |
le |
nit |
pip/ taz |
tmp/ smx |
|
Acinetobacter baumannii |
43 |
- |
77 |
- |
43 |
23 |
- |
- |
- |
61 |
27 |
- |
- |
30 |
|
Citrobacter freundii |
55 |
100 |
- |
0 |
100 |
78 |
87 |
- |
98 |
93 |
84 |
89 |
- |
71 |
|
Citrobacter koseri |
50 |
100 |
- |
92 |
100 |
96 |
100 |
- |
100 |
100 |
64 |
54 |
- |
68 |
|
Enterobacter aerogenes |
43 |
100 |
- |
0 |
100 |
77 |
79 |
- |
98 |
93 |
86 |
7 |
- |
93 |
|
Enterobacter cloacae |
128 |
100 |
- |
0 |
94 |
53 |
58 |
- |
84 |
89 |
62 |
18 |
- |
66 |
|
Escherichia coli |
3152 |
100 |
45 |
80 |
88 |
86 |
87 |
12 |
100 |
80 |
41 |
89 |
- |
54 |
|
Klebsiella oxytoca |
57 |
100 |
84 |
81 |
100 |
100 |
98 |
2 |
100 |
100 |
96 |
63 |
- |
95 |
|
Klebsiella pneumoniae |
653 |
99 |
85 |
89 |
92 |
90 |
91 |
8 |
100 |
96 |
93 |
25 |
- |
88 |
|
Morganella morganii |
96 |
99 |
0 |
0 |
92 |
60 |
90 |
- |
100 |
75 |
41 |
0 |
- |
30 |
|
Proteus mirabilis |
1144 |
100 |
66 |
86 |
97 |
97 |
97 |
- |
100 |
76 |
28 |
0 |
- |
36 |
|
Providencia stuartii |
115 |
99 |
0 |
0 |
99 |
96 |
99 |
- |
- |
47 |
11 |
0 |
- |
42 |
|
Pseudomonas aeruginosa |
488 |
95 |
- |
- |
74 |
75 |
- |
- |
- |
65 |
42 |
- |
78 |
- |
|
Serratia marcescens |
31 |
100 |
0 |
0 |
100 |
94 |
97 |
- |
100 |
91 |
88 |
0 |
- |
91 |
|
Stenotrophomonas maltophilia |
19* |
- |
- |
- |
- |
- |
- |
- |
- |
- |
74 |
- |
- |
100 |
*NO. of isolates-“Percent susceptible for each
organism/antimicrobial combination was generated by including the first isolate
of that organism recovered from a given patient.” When fewer that 30 isolates are
reported it should be noted that less than statistical validity of the
estimates of percent susceptibility exist.
Abbreviation Key: amk- amikacin,
am/s-ampicillin/sulbactam, cz-cefazolin, fep- cefepime, caz-ceftazidime,
cx-ceftriaxone, Esbl-Extended Spectrum
Beta Lactamase, etp-ertapenem, gm-gentamicin, le-levofloxacin,
nit-nitrofurantoin,
pip/taz-piperacillin/tazobactam, tmp.smx-trimethoprim/sulfa
- antibiotics not tested or not
recommended due to lack of correlation between in vitro results and in vivo
activity.